| CAS: | 1670-87-7 | ||||
| 分子式: | C9H8N2O | ||||
| 分子量: | 160.18 | ||||
| 沸点: | 457.6 °C at 760 mmHg | ||||
| 中文名称: |
| ||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||
| S933544 | MACKLIN | SD-169 | ≥98% | 240元/100mg; 367元/250mg; 989元/1g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:2-8°C,避光,干燥,密封 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Y10352 | Alfa Aesar | SD-169 | 5984元/100mg; 871元/250mg; 2261元/1g; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||
基本信息 分子量 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 506158 | Sigma-Aldrich | p38 MAP Kinase Inhibitor VII, SD-169-CAS 1670-87-7-Calbiochem | The p38 MAP Kinase Inhibitor VII, SD-169, also referenced under CAS 1670-87-7, controls the biological activity of p38 MAP Kinase. | 2741.8元/10 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 A cell-permeable indole compound that acts as a potent, ATP-competitive, and isozyme-selective p38α MAP kinase inhibitor (IC50 = 3.2 nM). It inhibits p38β only at much higher concentrations (IC50 = 122 nM) and exhibits little activity against p38γ, ERK2, JNK-1, or MAPKAPK-2 even at concentrations as high as 50 µM. When administered to NOD mice via food intake in vivo, SD-169 is shown to prevent the development of type 1 diabetes in prediabetic mice and display therapeutic efficacy in treating animals already in mild and moderate hyperglycemic states. 包装 10 mg in Plastic ampoule 警告 Toxicity: Harmful (C) 重悬 Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C. 其他说明 Medicherla, S., et al. 2006. J. Pharmacol. Exp. Ther.318, 99. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 050330 | Fluorochem | 1H-Indole-5-carboxamide | 97% | 1298元/250mg; 2838元/1g; 10824元/5g; 32472元/25g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||